Cryopyrin-Associated Periodic Syndrome Drug Pipeline Report 2024: Therapeutic Developments for Zydus Cadila, Novartis, Inflazome, Roche, Aclaris Therapeutics, and Mabpharm
April 25, 2024 07:43 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Cryopyrin-Associated Periodic Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offeringThe global medical...
US HUMIRA Market Projected for Extensive Growth by 2032 in Noninfectious Autoimmune Uveitis Sector
February 28, 2024 11:05 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "US HUMIRA Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. An insightful analysis...
Global Axial Spondyloarthritis (axSpA) Market Report 2023
January 30, 2024 20:24 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Axial Spondyloarthritis (axSpA) Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global axial...
Global Rheumatoid Arthritis (RA) Drugs Research Report 2024: Market Set for Marginal Growth to 2028 - Long-term Forecasts to 2033
January 30, 2024 10:36 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global Rheumatoid Arthritis...
Tumor Necrosis Factor (TNF) Inhibitor Drugs Market Outlook 2024-2028: Product Innovations and Strategic Partnerships Catalyzing Industry Growth
January 23, 2024 11:48 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The tumor necrosis...
Immunotherapy Advancements: CD40 Agonist and Antagonist Research Fuels Oncology and Autoimmunity Treatment Innovations
December 14, 2023 05:33 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. The global scientific community...
SIMPONI Emerging Drug Insights and Market Forecasts to 2032
December 13, 2023 04:08 ET
|
Research and Markets
Dublin, Dec. 13, 2023 (GLOBE NEWSWIRE) -- The "SIMPONI Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Emerging Trends in Treating Rheumatoid Arthritis: Biopharmaceuticals and Online Distribution Leading the Way
September 05, 2023 09:38 ET
|
Research and Markets
Dublin, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Drugs Market, Size, Share, Global Forecast 2023-2030, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"...
Personalized Medicine and Novel Therapies Propel Psoriatic Arthritis Treatment Market: Key Trends and Leading Company Profiles
August 09, 2023 08:13 ET
|
Research and Markets
Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis Treatment Market by Drug Type, Type, and Route of Administration: Global Opportunity Analysis and Industry Forecast, 2019-2027"...
Global Axial Spondyloarthritis Treatment Market Report 2023: Surge in Incidences of Axial Spondylarthritis Drives Growth
June 26, 2023 05:53 ET
|
Research and Markets
Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Axial Spondyloarthritis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027" report has been added to ...